Vimarsana
Biggest News Aggregation in the World

Page 48 - Acceleron Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acceleron Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acceleron Pharma Today - Breaking & Trending Today

Delix Therapeutics Named One of Fierce Biotech's "Fierce 15" Companies of 2021 - Vimarsana News

Delix Therapeutics Named One of Fierce Biotech's "Fierce 15" Companies of 2021

/PRNewswire/ -- Delix Therapeutics (the "Company") is honored to have been named by Fierce Biotech as one of 2021's "Fierce 15" biotechnology companies,...

Get Ready for a Biotech M&A Comeback | Chief Investment Officer - Vimarsana News

Get Ready for a Biotech M&A Comeback | Chief Investment Officer

 RBC Capital, heartened by some billion-dollar-plus deals, sees a new buyout hunger in Big Pharma.

Source: ai-cio.com
Merck Is a Buy, Guilfoyle Says - Vimarsana News

Merck Is a Buy, Guilfoyle Says

Drug treatment for COVID is likely game changer for pandemic.

Bristol Myers Squibb: Should You Buy the Dip? - Vimarsana News

Bristol Myers Squibb: Should You Buy the Dip?

Short-term volatility can be a patient, long-term investor's best friend.

Source: fool.com
Is Merck a Buy After Covid-Treatment Report? Check the Chart. - Vimarsana News

Is Merck a Buy After Covid-Treatment Report? Check the Chart.

Merck is at 52-week highs after the health-care giant reported progress with its Covid treatment. Here's the chart and outlook.